ProteoMediX AG

Wagistr. 23
8952 Schlieren
Auf der Karte anzeigen

Mitarbeiter CH: 6
Branche: Chemie/ Pharma
Umsatz Vorjahr: Keine Informationen vorhanden
Information Börse: Keine Informationen vorhanden
Weitere Informationen

ProteoMediX is a spinoff company of ETH Zurich and specialized in the development of novel biomarkers for the early detection of cancer and the personalized treatment thereof.
The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard. This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

Komplette Beschreibung

Offene Stellen bei ProteoMediX AG